Mary Jo LaDu, Blaine Staine Jr, Masaaki Narita, Godfrey Getz, Catherine Reardon, Guojun Bu
Self-assembly of HEK cell-secreted ApoE enrichment of lipoproteins as a ligand for the LDL receptor-related protein
Biochemistry, 2006; 45(2), 381-390.

Ryoichi Sakuta, Mami Tazoe, Masaaki Narita, Naoko Narita
Anxiety Status in School Refusal Children with Indefinite Complaints: Psychological Evaluation Using State-Trait Anxiety Inventry (STAI) and Therapeutic Potential by Selective Serotonin Reuptake Inhibitor (SSRIs).
In: Anne C. Shirley, editor. Focus on Serotonin Uptake Inhibitor Research. New York: Nova Science Publishers, 2006; 83-100

成田正明、成田奈緒子
血清神経栄養因子による脳発達障害の診断
Clinical Neuroscience, 2006; 3, 258-259

成田正明、成田奈緒子、倉恒弘彦、渡辺恭良
慢性疲労症候群の分子遺伝的背景
Progress in Medicine, 2005; 25: 1255-1259.

成田奈緒子、成田正明、永井敏郎
小児の突然死の原因
日本医事新報　2005; 4235: 90-92.

Kaoru Miyazaki, Naoko Narita, Masaaki Narita.
Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring : implication for pathogenesis of autism
International Journal of Developmental Neuroscience, 2005; 23: 287-297.

Fumie Naka, Naoko Narita, Nobuo Okado, Masaaki Narita.
Modification of AMPA receptor properties following environmental enrichment.
Brain and Development, 2005; 27: 275-278.

成田奈緒子、成田正明
心のはたらきと脳.　
子どもと発育発達、2004, 2; 182-184.

倉恒弘彦、上田素子、成田正明、成田奈緒子、志水彰、渡辺恭良
慢性疲労症候群のリスクファクター
モレキュラーメディシン2004; 41(10): 1243-1250.

成田正明、成田奈緒子.
発達障害のモデル動物研究の研究と現状.
精神保健研究、2004; 17: 49-54.

Kaoru Miyazaki, Naoko Narita, Ryoichi Sakuta, Tomoko Miyahara, Hiroshi Naruse, Nobuo Okado, Masaaki Narita.
Serum neurotrophin concentrations in autism and mental retardation ; a pilot study.
Brain and Development, 2004; 26(5), 292-295.

Aika Yajima, Mariko Ikeda, Kaoru Miyazaki, Toru Maeshima, Naoko Narita, Masaaki Narita.
Manserin, a novel peptide from secretogranin II in the neuroendocrine system.
Neuroreport, 2004; 15: 1755-1759.

成田正明、成田奈緒子.
サリドマイドと自閉症モデル動物.
Clinical Neuroscience 2003; 21: 1208.

成田正明、成田奈緒子.
SIDSの新しい危険因子についての検討.
日本小児救急医学会雑誌2003;1:13-15.

成田正明、岡戸信男.
セロトニン神経の発達とシナプス形成.
Clinical Neuroscience 2003; 21: 622-625.

Masaaki Narita, David M Holtzman, Anne M Fagan, Mary Jo LaDu, Li Yu, Xianlin Han, Richard W Gross, Guojun Bu, Alan L Schwartz.

Cellular catabolism of lipid poor apolipoprotein E via cell surface LDL receptor-related protein.

Journal of Biochemistry 2002; 132: 743-749.

Naoko Narita, Michiko Kato, Mami Tazoe, Kaoru Miyazaki, Masaaki Narita, Nobuo Okado.

Increased monoamine concentration in the brain and the blood of fetal thalidomide and valproic acid exposed rat ; putative animal models for autism.

Pediatric Research 2002; 52: 576-579.

Nobuo Okado, Masaaki Narita, Naoko Narita.
A Serotonin malfunction hypothesis by finding clear mutual relationships between several risk factors and symptoms associated with sudden infant death syndrome.
Medical Hypothesis 2002; 58: 232-236.

Masaaki Narita, Naoko Nishigami, Naoko Narita, Kouzi yamaguti, Nobuo Okado, Yasuyoshi Watanabe, Hirohiko Kuratsune.

Association between Serotonin Transporter Gene Polymorphism and Chronic Fatigue Syndrome. Biochemical and Biophysical Research Communications 2003; 311: 264-266.

岡戸信男、成田奈緒子、成田正明.
生体アミン神経系の機能障害から子供の脳を守る―精神遅滞・発達障害と乳幼児突然死症候群の発症機構
ベビーサイエンス　2001; 1: 23-51.

Nobuo Okado, Masaaki Narita, Naoko Narita.
Biogenic amine-synapse mechanism for mental retardation and developmental disabilities. 
Brain & Development 2001; 23: 1,11-15.

Naoko Narita, Masaaki Narita, Sachio Takashima, Masahiro Nakayama,  Toshiro Nagai, Nobuo Okado.

Serotonin transporter gene variation is a risk factor for sudden infant death syndrome in Japanese population.

Pediatrics 2001; 107: 690-692.